TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis

Area of Science:

• Developmental Biology
• Molecular Biology
• Cardiovascular Research

Background:

• Transforming growth factor beta-1 (TGF beta-1) is a key signaling molecule in embryonic development.
• Understanding TGF beta-1 expression patterns is crucial for elucidating cardiac development mechanisms.

Purpose of the Study:

• To map the spatiotemporal distribution of TGF beta-1 RNA in developing mouse embryos and hearts.
• To compare TGF beta-1 RNA distribution with TGF beta polypeptide and J1/tenascin extracellular matrix proteins.

Main Methods:

• Whole mount in situ hybridization for TGF beta-1 RNA detection in mouse embryos (implantation to 10.5 days postcoitum).
• Analysis of postnatal heart development up to 8 days postpartum.
• Comparison of RNA distribution with immunohistochemical localization of TGF beta and J1/tenascin.

Main Results:

• High TGF beta-1 RNA levels observed in cardiac mesoderm at 7.0 days postcoitum.
• Expression localized to endocardial cells by 8.0 days gestational age, then to cells overlying cardiac cushions by 9.5 days.
• Persistent expression in heart valve endothelial cells until one week postpartum.
• Correlation between endothelial TGF beta-1 RNA and mesenchymal TGF beta polypeptide suggests paracrine signaling.
• Correlation between TGF beta-1 RNA and J1/tenascin distribution supports J1/tenascin mediating TGF beta-1 effects.

Conclusions:

• TGF beta-1 plays a significant role in early cardiac development, with specific expression patterns in key cardiac cell types.
• Paracrine signaling of TGF beta-1 is implicated in cardiac development.
• J1/tenascin may be involved in mediating the biological effects of TGF beta-1 during heart development.